PBH +3.54%: the sports wagering business bounced today after announcing pre-registrations had opened in New York ahead of the final approvals from the New York State Gaming Commission. While the launch isn’t expected until the end of the month, PointsBet have been authorised to get the ball rolling. They also announced a deal with the NHL Alumni Association, the largest membership group of retired NHL players in Canada. The partnership will promote safe wagering working in tandem with PointsBet’s agreement in the NHL. While it’s been a very tough period for PBH in terms of share price, and the position is our weakest of the Emerging Companies portfolio, we do remain positive that the business has got operational momentum in a large, albeit competitive market.
scroll
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
A discussion with Geoff Wilson – Wilson Asset Management & James Gerrish – Market Matters
Close
Thursday 17th April – ASX +24pts, CGF, BHP, STO
Close
Thursday 17th April – Dow -699pts, SPI down -26pts
Close
MM remains optimistic on PBH
Add To Hit List
Related Q&A
Why would MM sell DUB/PBH?
What’s MM’s longer term view towards PBH?
MM’s thoughts on PBH & DUB
MM’s view on PointsBet (PBH) & a2 Milk (A2M)
Thoughts on Aristocrat (ALL) and PointsBet (PBH)
Thoughts on Pointsbet & Nitro?
Do you think the current dip a good opportunity to add or build positions?
Codan (CDA) & PointsBet (PBH) – whats going on?
What stocks would we top up here?
Is PointsBet (PBH) worth a punt?
Relevant suggested news and content from the site

Video
WATCH
A discussion with Geoff Wilson – Wilson Asset Management & James Gerrish – Market Matters
Recorded Monday 31st March

Podcast
LISTEN
Thursday 17th April – ASX +24pts, CGF, BHP, STO
Daily Podcast Direct from the Desk

Podcast
LISTEN
Thursday 17th April – Dow -699pts, SPI down -26pts
Daily Podcast Direct from the Desk
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.